<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[pill Resources | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/pill.html]]></link>
	<description><![CDATA[White papers, case studies, business articles, and blog posts relating to pill]]></description>
	<s:counts start="0" returned="20" found="52" />
	<language>en-us</language>
	<item>
		<title><![CDATA[Novartis Chip Implant Texts Your Phone When You Need Another Pill]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10004443/novartis-chip-implant-texts-your-phone-when-you-need-another-pill/]]></link>
		<description><![CDATA[Novartis implanted computer chips into the shoulders of 20 patients taking the blood pressure drug Diovan; the chips sent text messages to their cellphones when it was time to take the next pill. The experiment was designed to improve "compliance." (Lousy compliance is the phenomenon of patients receiving prescriptions but...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Tue, 22 Sep 2009 16:04:26 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/patient.html"><![CDATA[Patient]]></category>
		<category domain="http://resources.bnet.com/topic/phone.html"><![CDATA[Phone]]></category>
		<category domain="http://resources.bnet.com/topic/compliance.html"><![CDATA[Compliance]]></category>
		<category domain="http://resources.bnet.com/topic/novartis+ag.html"><![CDATA[Novartis AG]]></category>
		<category domain="http://resources.bnet.com/topic/pill.html"><![CDATA[Pill]]></category>
		<category domain="http://resources.bnet.com/topic/chip.html"><![CDATA[Chip]]></category>
		<category domain="http://resources.bnet.com/topic/semiconductors.html"><![CDATA[Semiconductors]]></category>
		<category domain="http://resources.bnet.com/topic/network+technology.html"><![CDATA[Network Technology]]></category>
		<category domain="http://resources.bnet.com/topic/hardware.html"><![CDATA[Hardware]]></category>
		<category domain="http://resources.bnet.com/topic/networking.html"><![CDATA[Networking]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NVS</category>
		<category domain="tickers">NVS</category>
	</item>
	<item>
		<title><![CDATA[InterMune, Inc. Q2 2009 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-329552.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator Operator instructions Your first question comes from Brian Abrahams from Oppenheimer. Your line is now open. Brian Abrahams &#8211; Oppenheimer & Co. Hi, thanks very much for taking my questions. Can you hear me okay? Dan Welch Yes, Brian. We can. Brian Abrahams &#8211; Oppenheimer & Co....]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<pubDate>Thu, 06 Aug 2009 18:23:15 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/roche+holding+ag.html"><![CDATA[Roche Holding AG]]></category>
		<category domain="http://resources.bnet.com/topic/oppenheimer+%2526+co..html"><![CDATA[Oppenheimer & Co.]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/pill.html"><![CDATA[Pill]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/intermune+inc..html"><![CDATA[InterMune Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ITMN</category>
		<category domain="tickers">ITMN</category>
	</item>
	<item>
		<title><![CDATA[Arena Lays Off 31% of Its Staff Following Obesity Trial Failure]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10001832/arena-lays-off-31-of-its-staff-following-obesity-trial-failure/]]></link>
		<description><![CDATA[Arena Pharmaceuticals is to lay off 31 percent, or 130 employees, before June 22, the company told the SEC. Arena staffers -- whose future is dependent on an anti-obesity drug, lorcaserin -- may be forgiven for wondering how it has all gone wrong so quickly.  In February, Arena CEO...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Mon, 27 Apr 2009 12:23:07 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/pill.html"><![CDATA[Pill]]></category>
		<category domain="http://resources.bnet.com/topic/amylin.html"><![CDATA[Amylin]]></category>
		<category domain="http://resources.bnet.com/topic/sales+strategy.html"><![CDATA[Sales Strategy]]></category>
		<category domain="http://resources.bnet.com/topic/federal+government.html"><![CDATA[Federal Government]]></category>
		<category domain="http://resources.bnet.com/topic/sales+force+management.html"><![CDATA[Sales Force Management]]></category>
		<category domain="http://resources.bnet.com/topic/sales.html"><![CDATA[Sales]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
	</item>
	<item>
		<title><![CDATA[Landmark Ruling On Drug Cases]]></title>
		<link><![CDATA[http://moneywatch.bnet.com/economic-news/video/landmark-ruling-on-drug-cases/275964/]]></link>
		<description><![CDATA[In the wake of a recent lawsuit involving the drug company Wyeth, the Supreme Court has ruled that the FDA is not exclusively responsible for the safety of prescription drugs. Wyatt Andrews reports.]]></description>
		<s:doctype><![CDATA[Videos]]></s:doctype>
		<pubDate>Wed, 15 Apr 2009 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/moneywatch.html"><![CDATA[MoneyWatch]]></category>
		<category domain="http://resources.bnet.com/topic/federal+government.html"><![CDATA[Federal Government]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/evening.html"><![CDATA[Evening]]></category>
		<category domain="http://resources.bnet.com/topic/drug.html"><![CDATA[Drug]]></category>
		<category domain="http://resources.bnet.com/topic/prescription.html"><![CDATA[Prescription]]></category>
		<category domain="http://resources.bnet.com/topic/medicine.html"><![CDATA[Medicine]]></category>
		<category domain="http://resources.bnet.com/topic/pill.html"><![CDATA[Pill]]></category>
		<category domain="http://resources.bnet.com/topic/health.html"><![CDATA[Health]]></category>
		<category domain="http://resources.bnet.com/topic/law.html"><![CDATA[Law]]></category>
		<category domain="http://resources.bnet.com/topic/legal.html"><![CDATA[Legal]]></category>
		<category domain="http://resources.bnet.com/topic/justice.html"><![CDATA[Justice]]></category>
		<category domain="http://resources.bnet.com/topic/federal.html"><![CDATA[Federal]]></category>
	</item>
	<item>
		<title><![CDATA[Vivus Beating Arena, Orexigen In Obesity Graveyard Race]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10001541/vivus-beating-arena-orexigen-in-obesity-graveyard-race/]]></link>
		<description><![CDATA[The race to produce a blockbuster anti-obesity pill -- a contest that no company has yet won -- got interesting this week with the news, via AP, that Arena Pharmaceuticals' data showed that its contender, lorcaserin, showed only 3.6 percent more effectiveness than a placebo. The FDA wants to see...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Tue, 31 Mar 2009 11:41:32 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/pill.html"><![CDATA[Pill]]></category>
		<category domain="http://resources.bnet.com/topic/drug.html"><![CDATA[Drug]]></category>
		<category domain="http://resources.bnet.com/topic/federal+government.html"><![CDATA[Federal Government]]></category>
		<category domain="http://resources.bnet.com/topic/sales+strategy.html"><![CDATA[Sales Strategy]]></category>
		<category domain="http://resources.bnet.com/topic/investment.html"><![CDATA[Investment]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/sales.html"><![CDATA[Sales]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[Finance]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
	</item>
	<item>
		<title><![CDATA[FDA Moves Against Unapproved Obesity Drugs]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/1000575/fda-moves-against-unapproved-obesity-drugs/]]></link>
		<description><![CDATA[The FDA has published a list of unapproved, "tainted," or "undeclared" weight-loss drugs that it wants off the market. The list includes rimonabant and sibutramine. Rimonabant was the active ingredient in Zimulti/Acomplia, the ill-fated obesity treatment that Sanofi-Aventis tried to get approved in the U.S. The FDA turned the application...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Fri, 09 Jan 2009 07:40:33 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/pill.html"><![CDATA[Pill]]></category>
		<category domain="http://resources.bnet.com/topic/sibutramine.html"><![CDATA[Sibutramine]]></category>
		<category domain="http://resources.bnet.com/topic/meridia.html"><![CDATA[Meridia]]></category>
		<category domain="http://resources.bnet.com/topic/vivus.html"><![CDATA[Vivus]]></category>
		<category domain="http://resources.bnet.com/topic/federal+government.html"><![CDATA[Federal Government]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
	</item>
	<item>
		<title><![CDATA[Altus Pharmaceuticals Inc. Q3 2008 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-250979.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator Operator instructions We will pause just a moment to give everyone a chance to signal. And we go first to Eric Schmidt with Cowen & Co. Eric Schmidt &#8211; Cowen & Co. Good morning, Georges. In terms of your upcoming meeting with the FDA on Trizytek, do...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<pubDate>Thu, 20 Nov 2008 00:37:15 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/eric+schmidt.html"><![CDATA[Eric Schmidt]]></category>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/patient.html"><![CDATA[Patient]]></category>
		<category domain="http://resources.bnet.com/topic/cowen+%2526+co..html"><![CDATA[Cowen & Co.]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/pill.html"><![CDATA[Pill]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/altus+pharmaceuticals+inc..html"><![CDATA[Altus Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/trizytek.html"><![CDATA[Trizytek]]></category>
		<category domain="http://resources.bnet.com/topic/federal+government.html"><![CDATA[Federal Government]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://resources.bnet.com/topic/eric+schmidt.html"><![CDATA[Eric Schmidt]]></category>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/patient.html"><![CDATA[Patient]]></category>
		<category domain="http://resources.bnet.com/topic/cowen+%2526+co..html"><![CDATA[Cowen & Co.]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/pill.html"><![CDATA[Pill]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/altus+pharmaceuticals+inc..html"><![CDATA[Altus Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/trizytek.html"><![CDATA[Trizytek]]></category>
		<category domain="http://resources.bnet.com/topic/federal+government.html"><![CDATA[Federal Government]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ALTU</category>
		<category domain="tickers">ALTU</category>
	</item>
	<item>
		<title><![CDATA[A Pill for Entrepreneurialism?]]></title>
		<link><![CDATA[http://blogs.bnet.com/bnet1/?p=710]]></link>
		<description><![CDATA[  	The Find: Research at a leading university reveals not only that entrepreneurs are riskier decision makers than managers, but also suggests that, in the future, those who'd like to develop a more entrepreneurial frame of mind could either take a class or take a pill.  	The Source:...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Thu, 13 Nov 2008 04:27:41 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/entrepreneur.html"><![CDATA[Entrepreneur]]></category>
		<category domain="http://resources.bnet.com/topic/decision-making.html"><![CDATA[Decision-making]]></category>
		<category domain="http://resources.bnet.com/topic/pill.html"><![CDATA[Pill]]></category>
		<category domain="http://resources.bnet.com/topic/entrepreneurship.html"><![CDATA[Entrepreneurship]]></category>
		<category domain="http://resources.bnet.com/topic/management.html"><![CDATA[Management]]></category>
		<category domain="http://resources.bnet.com/topic/jessica+stillman.html"><![CDATA[Jessica Stillman]]></category>
		<category domain="http://resources.bnet.com/topic/entrepreneur.html"><![CDATA[Entrepreneur]]></category>
		<category domain="http://resources.bnet.com/topic/decision-making.html"><![CDATA[Decision-making]]></category>
		<category domain="http://resources.bnet.com/topic/pill.html"><![CDATA[Pill]]></category>
		<category domain="http://resources.bnet.com/topic/entrepreneurship.html"><![CDATA[Entrepreneurship]]></category>
		<category domain="http://resources.bnet.com/topic/management.html"><![CDATA[Management]]></category>
		<category domain="http://resources.bnet.com/topic/jessica+stillman.html"><![CDATA[Jessica Stillman]]></category>
	</item>
	<item>
		<title><![CDATA[Solvay, Pfizer, Sanofi Join Merck in Abandoning Obesity Drugs]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/1000366/pfizer-and-sanofi-join-merck-in-abandoning-obesity-drugs/]]></link>
		<description><![CDATA[For those of you hoping that Americaâ€™s obesity crisis could be solved with a pill, think again. Pfizer announced late Wednesday that it is scrapping its anti-fat drug, the as-yet unnamed â€œCP-945,598,â€ for essentially political reasons. Sanofi-Aventis today also announced that it was ending its trials on Acomplia/Zimulti, an obesity...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Wed, 05 Nov 2008 18:25:05 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/pfizer+inc..html"><![CDATA[Pfizer Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/merck+%2526+co.+inc..html"><![CDATA[Merck & Co. Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/pill.html"><![CDATA[Pill]]></category>
		<category domain="http://resources.bnet.com/topic/sanofi.html"><![CDATA[Sanofi]]></category>
		<category domain="http://resources.bnet.com/topic/research+%2526+development.html"><![CDATA[Research & Development]]></category>
		<category domain="http://resources.bnet.com/topic/real+estate.html"><![CDATA[Real Estate]]></category>
		<category domain="http://resources.bnet.com/topic/food+%2526+beverage.html"><![CDATA[Food & Beverage]]></category>
		<category domain="http://resources.bnet.com/topic/regulations.html"><![CDATA[Regulations]]></category>
		<category domain="http://resources.bnet.com/topic/business+operations.html"><![CDATA[Business Operations]]></category>
		<category domain="http://resources.bnet.com/topic/manufacturing.html"><![CDATA[Manufacturing]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://resources.bnet.com/topic/pfizer+inc..html"><![CDATA[Pfizer Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/merck+%2526+co.+inc..html"><![CDATA[Merck & Co. Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/pill.html"><![CDATA[Pill]]></category>
		<category domain="http://resources.bnet.com/topic/sanofi.html"><![CDATA[Sanofi]]></category>
		<category domain="http://resources.bnet.com/topic/research+%2526+development.html"><![CDATA[Research & Development]]></category>
		<category domain="http://resources.bnet.com/topic/real+estate.html"><![CDATA[Real Estate]]></category>
		<category domain="http://resources.bnet.com/topic/food+%2526+beverage.html"><![CDATA[Food & Beverage]]></category>
		<category domain="http://resources.bnet.com/topic/regulations.html"><![CDATA[Regulations]]></category>
		<category domain="http://resources.bnet.com/topic/business+operations.html"><![CDATA[Business Operations]]></category>
		<category domain="http://resources.bnet.com/topic/manufacturing.html"><![CDATA[Manufacturing]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MRK</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">PFE</category>
		<category domain="tickers">MRK,PFE</category>
	</item>
	<item>
		<title><![CDATA[Isiah Thomas Overdose Indicates Lunesta Has Chink in Armor]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/1000339/isiah-thomas-overdose-indicates-lunesta-has-chink-in-armor/]]></link>
		<description><![CDATA[Until now, Sepracorâ€™s Lunesta sleeping pill has enjoyed one advantage over Sanofi-Aventisâ€™s Ambien CR: a superior reputation for safety. The drug is approved by the FDA for long-term use, unlike many of its rivals. And itâ€™s not a benzodiazepine.    That reputation changed over the weekend as it...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Sun, 26 Oct 2008 19:02:33 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/sepracor+inc..html"><![CDATA[Sepracor Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/pill.html"><![CDATA[Pill]]></category>
		<category domain="http://resources.bnet.com/topic/isiah+thomas+overdose.html"><![CDATA[Isiah Thomas Overdose]]></category>
		<category domain="http://resources.bnet.com/topic/federal+government.html"><![CDATA[Federal Government]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/sepracor+inc..html"><![CDATA[Sepracor Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/pill.html"><![CDATA[Pill]]></category>
		<category domain="http://resources.bnet.com/topic/isiah+thomas+overdose.html"><![CDATA[Isiah Thomas Overdose]]></category>
		<category domain="http://resources.bnet.com/topic/federal+government.html"><![CDATA[Federal Government]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">SEPR</category>
		<category domain="tickers">SEPR</category>
	</item>
	<item>
		<title><![CDATA[BNET Focus on Antidepressants: Part 1, Sales and Strategy]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/1000246/bnet-focus-on-antidepressants-part-1-sales-and-strategy/]]></link>
		<description><![CDATA[Ever since Eli Lilly launched Prozac in the U.S. in 1987, Americans have had a love affair with anti-depressants. Prozac isn't just a pill. It was the cultural touchstone of 1990s -- as a lifesaver, punchline and punching bag.    When Prozac went off-patent in 2001, something interesting...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Tue, 30 Sep 2008 06:00:26 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/wyeth.html"><![CDATA[Wyeth]]></category>
		<category domain="http://resources.bnet.com/topic/pill.html"><![CDATA[Pill]]></category>
		<category domain="http://resources.bnet.com/topic/lilly.html"><![CDATA[Lilly]]></category>
		<category domain="http://resources.bnet.com/topic/sales+strategy.html"><![CDATA[Sales Strategy]]></category>
		<category domain="http://resources.bnet.com/topic/sales+force+management.html"><![CDATA[Sales Force Management]]></category>
		<category domain="http://resources.bnet.com/topic/strategy.html"><![CDATA[Strategy]]></category>
		<category domain="http://resources.bnet.com/topic/sales.html"><![CDATA[Sales]]></category>
		<category domain="http://resources.bnet.com/topic/management.html"><![CDATA[Management]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">WYE</category>
		<category domain="tickers">WYE</category>
	</item>
	<item>
		<title><![CDATA[A "Chewable" Poison Pill?]]></title>
		<link><![CDATA[http://blogs.bnet.com/ceo/?p=1188]]></link>
		<description><![CDATA[Remember the scene in the movie "M*A*S*H*" when Painless the dentist decides to commit suicide by downing the poisonous "Black Capsule?" Following a Last Supper-style scene with his cronies and some tender nursing care, however, Painless comes back to life.    Well, that's sort of what what Harvard...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Wed, 25 Jun 2008 11:33:12 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[Finance]]></category>
		<category domain="http://resources.bnet.com/topic/peter+galuszka.html"><![CDATA[Peter Galuszka]]></category>
		<category domain="http://resources.bnet.com/topic/investment.html"><![CDATA[Investment]]></category>
		<category domain="http://resources.bnet.com/topic/financial+accounting.html"><![CDATA[Financial Accounting]]></category>
		<category domain="http://resources.bnet.com/topic/pill.html"><![CDATA[Pill]]></category>
		<category domain="http://resources.bnet.com/topic/mergers+%2526+acquisitions.html"><![CDATA[Mergers & Acquisitions]]></category>
		<category domain="http://resources.bnet.com/topic/shareholder.html"><![CDATA[Shareholder]]></category>
		<category domain="http://resources.bnet.com/topic/lbo.html"><![CDATA[LBO]]></category>
		<category domain="http://resources.bnet.com/topic/poison+pill.html"><![CDATA[Poison Pill]]></category>
	</item>
	<item>
		<title><![CDATA[Are You Charging Way Too Little?]]></title>
		<link><![CDATA[http://blogs.bnet.com/salesmachine/?p=262]]></link>
		<description><![CDATA[Apparently, the best way to close as sale may be to charge ten times as much as your competition.  I'm not entirely certain that it would work in B2B, but there may be something here.  Let's start with some examples from real life.    There's a...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Tue, 11 Mar 2008 05:30:50 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/geoffrey+james.html"><![CDATA[Geoffrey James]]></category>
		<category domain="http://resources.bnet.com/topic/sales.html"><![CDATA[Sales]]></category>
		<category domain="http://resources.bnet.com/topic/internet.html"><![CDATA[Internet]]></category>
		<category domain="http://resources.bnet.com/topic/e-business%252fe-commerce.html"><![CDATA[E-business/E-Commerce]]></category>
		<category domain="http://resources.bnet.com/topic/sales+force+management.html"><![CDATA[Sales Force Management]]></category>
		<category domain="http://resources.bnet.com/topic/sales+strategy.html"><![CDATA[Sales Strategy]]></category>
		<category domain="http://resources.bnet.com/topic/b2b.html"><![CDATA[B2B]]></category>
		<category domain="http://resources.bnet.com/topic/luxury+good.html"><![CDATA[Luxury Good]]></category>
		<category domain="http://resources.bnet.com/topic/pill.html"><![CDATA[Pill]]></category>
	</item>
	<item>
		<title><![CDATA[Counterfeit drugs: Scientists call on Asia to cooperate more]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_kmafp/is_200802/ai_n21411670]]></link>
		<description><![CDATA[PARIS AFP &#8212; Scientists lifting the veil on a sting operation that netted drugs counterfeiters in China said on Tuesday it was vital for Asia's police and pharmaceutical watchdogs to work more closely in tackling these dangerous cheats.  In a paper published in the US online journal the Public...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 11 Feb 2008 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/agence+france-presse.html"><![CDATA[Agence France-Presse]]></category>
		<category domain="http://resources.bnet.com/topic/china.html"><![CDATA[China]]></category>
		<category domain="http://resources.bnet.com/topic/pill.html"><![CDATA[pill]]></category>
		<category domain="http://resources.bnet.com/topic/scientist.html"><![CDATA[scientist]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Thai candidates accused of vote-buying with Viagra: official]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_kmafp/is_200711/ai_n21133033]]></link>
		<description><![CDATA[BANGKOK AFP &#8212; Parliamentary candidates in Thailand's upcoming election are trying to buy the votes of elderly men by passing out free Viagra, a local government official said Friday.  Thais head to the polls on December 23 for the first time since the military toppled the elected prime minister...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 29 Nov 2007 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/agence+france-presse.html"><![CDATA[Agence France-Presse]]></category>
		<category domain="http://resources.bnet.com/topic/pill.html"><![CDATA[pill]]></category>
		<category domain="http://resources.bnet.com/topic/thailand.html"><![CDATA[Thailand]]></category>
		<category domain="http://resources.bnet.com/topic/viagra.html"><![CDATA[Viagra]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[New Medication Reminder System Takes Off]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2007_Nov_19/ai_n21107367]]></link>
		<description><![CDATA[Innovative Product Combines Monthly Medication Organizer with an Alarm Clock  Never Forget to Take your Pills Again!  CINCINNATI -- Sixty-four percent of adults with prescription medications say they have forgotten to take their medications within the past year. Now, patients and caregivers, grandparents and parents, children and adults...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 19 Nov 2007 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/components.html"><![CDATA[Components]]></category>
		<category domain="http://resources.bnet.com/topic/hardware.html"><![CDATA[HARDWARE]]></category>
		<category domain="http://resources.bnet.com/topic/medication.html"><![CDATA[medication]]></category>
		<category domain="http://resources.bnet.com/topic/pill.html"><![CDATA[pill]]></category>
		<category domain="http://resources.bnet.com/topic/retail.html"><![CDATA[Retail]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Pill misuse, not 9/11, blamed for man's death]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_qn4188/is_20071026/ai_n21078226]]></link>
		<description><![CDATA[NEW YORK AP -- The city's medical examiner concluded that the misuse of pills, not the dust of ground zero, caused the lung disease that killed a man who became a nationally known example of post-Sept. 11 illness, the examiner's spokeswoman confirmed Thursday.   Chief Medical Examiner Charles Hirsch...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 26 Oct 2007 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/associated+press.html"><![CDATA[Associated Press]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[HEALTHCARE]]></category>
		<category domain="http://resources.bnet.com/topic/pill.html"><![CDATA[pill]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Modern doctors speculate Louisa May Alcott had lupus]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_qn4188/is_20070815/ai_n19469984]]></link>
		<description><![CDATA[MINNEAPOLIS -- Louisa May Alcott is probably best known for her classic novel, "Little Women."   But it was the rash on her face in a 19th-century portrait that intrigued Dr. Ian Greaves of the University of Minnesota.   Greaves, a professor of environmental health, suspected that it...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 15 Aug 2007 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/diagnosis.html"><![CDATA[diagnosis]]></category>
		<category domain="http://resources.bnet.com/topic/dr..html"><![CDATA[Dr.]]></category>
		<category domain="http://resources.bnet.com/topic/pill.html"><![CDATA[pill]]></category>
		<category domain="http://resources.bnet.com/topic/portrait.html"><![CDATA[portrait]]></category>
		<category domain="http://resources.bnet.com/topic/university+of+minnesota.html"><![CDATA[University of Minnesota]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[The miracle pills of Friar Galvao, Brazil's soon to be saint]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_kmafp/is_200705/ai_n19056002]]></link>
		<description><![CDATA[SAO PAULO AFP &#8212; Day after day, cloistered Catholic nuns at a Sao Paulo monastery roll up thousands of tiny prayer scrolls credited with the miraculous powers of an 18th-century monk the pope will elevate to sainthood in this Brazilian city on Friday.  Outside the Monastery of Light, supplicants...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Sun, 06 May 2007 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/agence+france-presse.html"><![CDATA[Agence France-Presse]]></category>
		<category domain="http://resources.bnet.com/topic/brazil.html"><![CDATA[Brazil]]></category>
		<category domain="http://resources.bnet.com/topic/church.html"><![CDATA[Church]]></category>
		<category domain="http://resources.bnet.com/topic/pill.html"><![CDATA[pill]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[US wants stronger warnings on sleeping pills]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_kmafp/is_200703/ai_n18728212]]></link>
		<description><![CDATA[WASHINGTON AFP &#8212; The US Federal Drug Administration called Wednesday for popular sleeping pills such as Ambien and Lunesta to carry stronger warnings of dangerous potential side-effects like allergic reactions and sleep-driving.  The move comes a year after US lawmaker Patrick Kennedy, son of veteran Senator Ted Kennedy, crashed...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 14 Mar 2007 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/agence+france-presse.html"><![CDATA[Agence France-Presse]]></category>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/pill.html"><![CDATA[pill]]></category>
		<category domain="http://resources.bnet.com/topic/prescription.html"><![CDATA[prescription]]></category>
		<category domain="http://resources.bnet.com/topic/washington.html"><![CDATA[Washington]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
</channel>
</rss>
